NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 5.04% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 4.65% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 4.49% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.10% |
| UCB | UCB SA | Healthcare | Biotechnology | 4.06% |
| UMRX | Cogent Biosciences Inc | Healthcare | Biotechnology | 3.59% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 3.38% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.34% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 3.33% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.77% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 2.62% |
| LFST | Lifestance Health Group Inc | Healthcare | Medical Care Facilities | 2.28% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.26% |
| WAY | Waystar Holding Corp. Common Stock | Healthcare | Health Information Services | 2.26% |
| DIM | Sartorius Stedim Biotech SA | Healthcare | Medical Instruments & Supplies | 2.11% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.06% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.02% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 1.97% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.90% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.88% |